MycoMedica

MycoMedica Life Sciences, PBC is a clinical-stage biopharmaceutical company founded by mycologist Paul Stamets and backed by Obvious Ventures, True Ventures, and Kittyhawk Ventures. The company develops fungi-derived therapeutic drugs, including its lead psilocybin candidate MLS101 and the "Stamets Stack" (a novel blend of niacin, psilocybin, and lion's mane), for the prevention and treatment of psychiatric and neurological disorders. It raised $60 million in Series A funding in 2022 and is advancing pre-clinical and clinical research toward FDA approval. MycoMedica is a life-sciences drug-development company and publishes no public developer API, documentation, or developer portal.

MycoMedica is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Life Sciences, Drug Development, and Psychedelics.

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiopharmaceuticalLife SciencesDrug DevelopmentPsychedelicsMental HealthNeuroscienceMycology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 5.7/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/mycomedica: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: mycomedica
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/mycomedica.png
name: MycoMedica
description: MycoMedica Life Sciences, PBC is a clinical-stage biopharmaceutical company founded by mycologist Paul Stamets
  and backed by Obvious Ventures, True Ventures, and Kittyhawk Ventures. The company develops fungi-derived therapeutic drugs,
  including its lead psilocybin candidate MLS101 and the "Stamets Stack" (a novel blend of niacin, psilocybin, and lion's
  mane), for the prevention and treatment of psychiatric and neurological disorders. It raised $60 million in Series A funding
  in 2022 and is advancing pre-clinical and clinical research toward FDA approval. MycoMedica is a life-sciences drug-development
  company and publishes no public developer API, documentation, or developer portal.
url: https://raw.githubusercontent.com/api-evangelist/mycomedica/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- obvious-ventures
x-tier: stub
x-tier-reason: portfolio-lead
x-api-surface: none
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biopharmaceutical
- Life Sciences
- Drug Development
- Psychedelics
- Mental Health
- Neuroscience
- Mycology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.mycomedica.com
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1